Patents by Inventor Lisa-Anne Whittemore

Lisa-Anne Whittemore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Isolated cell comprising a nucleic acid encoding antibody inhibitors of gdf-8 and uses thereof
    Patent number: 9505831
    Abstract: The disclosure provides novel antibodies against growth and differentiation factor-8 (GDF-8), including antibody fragments, which inhibit GDF-8 activity in vitro and in vivo. The disclosure also provides methods for diagnosing, preventing, or treating degenerative disorders of muscle, bone, or insulin metabolism.
    Type: Grant
    Filed: April 18, 2014
    Date of Patent: November 29, 2016
    Assignee: Wyeth LLC
    Inventors: Jane Aghajanian, Neil M. Wolfman, Denise O'Hara, Monique V. Davies, Geertruida M. Veldman, Kristie Grove Bridges, Lisa-Anne Whittemore, Tejvir S. Khurana, Mary L. Bouxsein
  • Antibody Inhibitors of GDF-8 and Uses Thereof
    Publication number: 20150024484
    Abstract: The disclosure provides novel antibodies against growth and differentiation factor-8 (GDF-8), including antibody fragments, which inhibit GDF-8 activity in vitro and in vivo. The disclosure also provides methods for diagnosing, preventing, or treating degenerative disorders of muscle, bone, or insulin metabolism.
    Type: Application
    Filed: April 18, 2014
    Publication date: January 22, 2015
    Applicant: Wyeth LLC
    Inventors: Jane Aghajanian, Neil M. Wolfman, Denise O'Hara, Monique V. Davies, Geertruida M. Veldman, Kristie Grove Bridges, Lisa-Anne Whittemore, Tejvir S. Khurana, Mary L. Bouxsein
  • Isolated nucleic acid molecule encoding an antibody that reduces GDF-8 activity
    Patent number: 8710202
    Abstract: The disclosure provides novel antibodies against growth and differentiation factor-8 (GDF-8), including antibody fragments, which inhibit GDF-8 activity in vitro and in vivo. The disclosure also provides methods for diagnosing, preventing, or treating degenerative disorders of muscle, bone, or insulin metabolism.
    Type: Grant
    Filed: January 9, 2012
    Date of Patent: April 29, 2014
    Assignee: Wyeth LLC
    Inventors: Neil M. Wolfman, Denise O'Hara, Monique V. Davies, Geertruida M. Veldman, Kristie Grove Bridges, Lisa-Anne Whittemore, Tejvir S. Khurana, Mary L. Bouxsein, William J. Dunham
  • Antibody Inhibitors of GDF-8 and Uses Thereof
    Publication number: 20120107928
    Abstract: The disclosure provides novel antibodies against growth and differentiation factor-8 (GDF-8), including antibody fragments, which inhibit GDF-8 activity in vitro and in vivo. The disclosure also provides methods for diagnosing, preventing, or treating degenerative disorders of muscle, bone, or insulin metabolism.
    Type: Application
    Filed: January 9, 2012
    Publication date: May 3, 2012
    Applicant: Wyeth LLC
    Inventors: Jane Aghajanian, William J. Dunham, Neil M. Wolfman, Denise O'Hara, Monique V. Davies, Geertruida M. Veldman, Kristie Grove Bridges, Lisa-Anne Whittemore, Tejvir S. Khurana, Mary L. Bouxsein
  • Method of increasing trabecular bone density in a patient in need thereof by an antibody against GDF-8
    Patent number: 8092798
    Abstract: The disclosure provides novel antibodies against growth and differentiation factor-8 (GDF-8), including antibody fragments, which inhibit GDF-8 activity in vitro and in vivo. The disclosure also provides methods for diagnosing, preventing, or treating degenerative disorders of muscle, bone, or insulin metabolism.
    Type: Grant
    Filed: May 24, 2010
    Date of Patent: January 10, 2012
    Assignee: Wyeth LLC
    Inventors: Jane Aghajanian, William J. Dunham, legal representative, Neil M. Wolfman, Denise O'Hara, Monique V. Davies, Geertruida M. Veldman, Kristie Grove Bridges, Lisa-Anne Whittemore, Tejvir S. Khurana, Mary L. Bouxsein
  • ANTIBODY INHIBITORS OF GDF-8 AND USES THEREOF
    Publication number: 20110020330
    Abstract: The disclosure provides novel antibodies against growth and differentiation factor-8 (GDF-8), including antibody fragments, which inhibit GDF-8 activity in vitro and in vivo. The disclosure also provides methods for diagnosing, preventing, or treating degenerative disorders of muscle, bone, or insulin metabolism.
    Type: Application
    Filed: May 24, 2010
    Publication date: January 27, 2011
    Applicant: Wyeth
    Inventors: Jane Aghajanian, Neil M. Wolfman, Denise O'Hara, Monique V. Davies, Geertruida M. Veldman, Kristie Grove Bridges, Lisa-Anne Whittemore, Tejvir S. Khurana, Mary L. Bouxsein, William J. Dunham
  • THERAPEUTIC AND PROPHYLACTIC METHODS FOR NEUROMUSCULAR DISORDERS
    Publication number: 20100322942
    Abstract: The disclosure provides methods for treating neuromuscular disorders in mammals. The disclosed methods include administering therapeutically effective amounts of a GDF-8 inhibitor and a corticosteroid to a subject susceptible to, or having, a neuromuscular disorder, so as to maintain desirable levels of muscle function.
    Type: Application
    Filed: August 27, 2010
    Publication date: December 23, 2010
    Applicant: WYETH LLC
    Inventors: LISA-ANNE WHITTEMORE, XIANGPING LI
  • Therapeutic methods for muscular or neuromuscular disorders
    Patent number: 7785587
    Abstract: The disclosure provides methods for treating neuromuscular disorders in mammals. The disclosed methods include administering therapeutically effective amounts of a GDF-8 inhibitor and a corticosteroid to a subject susceptible to, or having, a neuromuscular disorder, so as to maintain desirable levels of muscle function.
    Type: Grant
    Filed: June 1, 2004
    Date of Patent: August 31, 2010
    Assignee: Wyeth
    Inventors: Lisa-Anne Whittemore, Xiangping Li
  • Methods of increasing muscle mass or muscle strength using antibody inhibitors of GDF-8
    Patent number: 7731961
    Abstract: The disclosure provides novel antibodies against growth and differentiation factor-8 (GDF-8), including antibody fragments, which inhibit GDF-8 activity in vitro and in vivo. The disclosure also provides methods for diagnosing, preventing, or treating degenerative disorders of muscle, bone, or insulin metabolism.
    Type: Grant
    Filed: April 19, 2007
    Date of Patent: June 8, 2010
    Assignee: Wyeth
    Inventors: Jane Aghajanian, William J. Dunham, legal representative, Neil M. Wolfman, Denise O'Hara, Monique V. Davies, Geertruida M. Veldman, Kristie Grove Bridges, Lisa-Anne Whittemore, Tejvir S. Khurana, Mary L. Bouxsein
  • Antibody inhibitors of GDF-8 and uses thereof
    Patent number: 7320789
    Abstract: The disclosure provides novel antibodies against growth and differentiation factor-8 (GDF-8), including antibody fragments, which inhibit GDF-8 activity in vitro and in vivo. The disclosure also provides methods for diagnosing, preventing, or treating degenerative disorders of muscle, bone, or insulin metabolism.
    Type: Grant
    Filed: September 25, 2002
    Date of Patent: January 22, 2008
    Assignee: Wyeth
    Inventors: William J. Dunham, legal representative, Neil M. Wolfman, Denise O'Hara, Monique V. Davies, Geertruida M. Veldman, Kristie Grove Bridges, Lisa-Anne Whittemore, Jane Aghajanian, deceased
  • Therapeutic and prophylactic methods for neuromuscular disorders
    Publication number: 20050014733
    Abstract: The disclosure provides methods for treating neuromuscular disorders in mammals. The disclosed methods include administering therapeutically effective amounts of a GDF-8 inhibitor and a corticosteroid to a subject susceptible to, or having, a neuromuscular disorder, so as to maintain desirable levels of muscle function.
    Type: Application
    Filed: June 1, 2004
    Publication date: January 20, 2005
    Inventors: Lisa-Anne Whittemore, Xiangping Li
  • Antibody inhibitors of GDF-8 and uses thereof
    Publication number: 20030138422
    Abstract: The disclosure provides novel antibodies against growth and differentiation factor-8 (GDF-8), including antibody fragments, which inhibit GDF-8 activity in vitro and in vivo. The disclosure also provides methods for diagnosing, preventing, or treating degenerative disorders of muscle, bone, or insulin metabolism.
    Type: Application
    Filed: September 25, 2002
    Publication date: July 24, 2003
    Inventors: Jane Aghajanian, William J. Dunham, Neil M. Wolfman, Denise O'Hara, Monique V. Davies, Geertruida M. Veldman, Kristie Grove Bridges, Lisa-Anne Whittemore, Tejvir S. Khurana, Mary L. Bouxsein